SCHEMBL3852886

SCHEMBL3852886

CS(=O)(=O)c1ccc(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4C(F)(F)F)cc23)s1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.33
CYP1A2 P05177 7/20 0.33
TSHR P16473 7/20 0.33
CYP2C19 P33261 7/20 0.33
CYP2D6 P10635 6/20 0.33
CLK4 Q9HAZ1 6/20 0.33
USP2 O75604 5/20 0.33
ALDH1A1 P00352 4/20 0.33
MAPK1 P28482 4/20 0.33
HIF1A Q16665 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 2/20 0.31
HSD17B10 Q99714 2/20 0.31
LMNA P02545 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854275 0.90 CYP3A4 (0.33) CYP3A4CYP1A2TSHRCYP2C19CYP2D6
SCHEMBL3848501 0.89 CA12 (0.35) CYP3A4CYP1A2TSHRCYP2C19CYP2D6
SCHEMBL3854489 0.88 PTGS2 (0.35) CYP3A4CYP1A2TSHRCYP2C19CYP2D6
SCHEMBL3853751 0.88 CA12 (0.40) CA12CA1CA2CA9PRMT5
SCHEMBL3846261 0.87 CA12 (0.34) CYP3A4CYP1A2TSHRCYP2C19CYP2D6
SCHEMBL3856217 0.86 CA12 (0.32) CA12CA1CA2CA9CD38
SCHEMBL3853047 0.86 CA12 (0.32) CYP3A4CYP1A2TSHRCYP2C19CYP2D6
SCHEMBL3849354 0.86 SCN9A (0.34) SCN9A
SCHEMBL3846708 0.86 PTGS1 (0.34) CYP3A4CYP1A2TSHRCYP2C19CYP2D6
SCHEMBL3850715 0.86 CYP1A2 (0.32) CYP3A4CYP1A2TSHRCYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed